October 26, 2004

Dear Conference Delegates,

It is with great pleasure that I offer a warm Louisville welcome to all delegates of the 2004 Annual Scientific Meeting of the *International Society for the Prevention of Tobacco Induced Diseases*.

Smoking kills 5 million people each year, an annual death toll that is expected soon to reach 10 million. Therefore, it is difficult to overestimate the importance of this global health concern. It is my sincere hope that the combined body of expertise assembling for this conference will contribute to reducing the tobacco-induced disease burden by disseminating the latest research findings, forming research collaborations, and assembling multidisciplinary alliances.

As you are aware Kentucky represents the heart of tobacco country and we have many lessons still to learn in the area of tobacco control. Thus, it is anticipated that the Louisville conference may help to promote tobacco control in our own region and, thus, have a long-lasting beneficial effect on our population.

During your visit, I do hope that you will find the time to relax and enjoy the wide range of activities that Louisville, and the surrounding countryside, has to offer.

Thank you for attending this important scientific conference, and again, welcome to Louisville.

Denis F. Kinane, BDS, PhD, FDS RCPS, FDS RCS

Delta Dental Endowed Professor

Associate Dean for Research and Enterprise
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**Accreditation Statement**

The University of Louisville School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
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Physicians wishing to receive Category 1 credit must complete and turn in the evaluation and registration for credit forms at the conclusion of the program. Please make sure your name, address, the last 4 digits of your Social Security number and license\# are clearly printed on the form.

The University of Louisville Continuing Health Sciences Education designates this educational activity for up to 14.3 hours in Category 1 credit towards the AMA physicians Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.

**Dental Credit**

Approved by the Kentucky Board of Dentistry for CE Credit as follows:

Saturday, October 30 -- 7 Hours, Category B

Sunday, October 31 -- 4.5 Hours, Category B

Monday, Nov. 1 -- 3.0 Hours, Category B

**Nursing Credit**

This program has been approved by the Kentucky Board of Nursing for a total of 17.2 contact hours through the University of Louisville School of Nursing: Saturday, 9.4 hrs (Provider Number 3-0046-7-05-062), Sunday, 4.2 hours (Provider Number 3-0046-7-05-064) Monday, 3.6 hours (Provider Number 3-0046-7-05-065) expiration date July 1, 2005. The Kentucky Board of Nursing approval of an individual nursing education provider does not constitute endorsement of program content. Participants must attend entire session, provide license and social security number, and complete evaluation to receive contact hours.

**AAFP Credit**

This activity has been reviewed and is acceptable for up to **13.50**Prescribed credit hours by the American Academy of Family Physicians.
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